
|Videos|February 24, 2023
A Cardiologist’s Perspective on Cardiovascular Risk Assessment in Prostate Cancer
Direct insight from a cardiologist on the advent of cardiovascular risk when treating a patient for prostate cancer.
Advertisement
Video Player is loading.
Episodes in this series

January 2023 AbbVie Inc. Company Confidential
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Christof Vulsteke, MD, PhD, breaks down findings, implications of KEYNOTE-905
2
The UroOnc Minute: Active Surveillance for Intermediate-risk Prostate Cancer, with Michael Leapman, MD, MHS
3
Petros Grivas, MD, on the significance of a perioperative regimen for cisplatin-ineligible MIBC
4
The Significance of KEYNOTE-905 in Muscle-Invasive Bladder Cancer
5



























